Home / Business and Economy / Indian Investors Bet on Unloved Stocks with Big Catalysts
Indian Investors Bet on Unloved Stocks with Big Catalysts
29 Jul
Summary
- Investor Ashish Dhawan increased stake in Religare Enterprises ahead of a demerger.
- Sunil Singhania re-entered TTK Healthcare just before a major brand sale.
- Both companies were previously overlooked, making these moves notable.
- Religare's demerger aims to separate insurance from lending and broking businesses.
- TTK Healthcare's brand sale to Wipro brings significant cash infusion.
Exchange filings reveal significant recent investments by prominent Indian investors Ashish Dhawan and Sunil Singhania in companies previously considered unloved. Dhawan has increased his stake in Religare Enterprises, a financial services holding company, from 4.12% to 5.24% before a planned demerger. This demerger, approved on May 12, 2026, will separate its Care Health Insurance business from its lending, broking, and other allied operations. The Burman family recently became promoters, increasing their stake to 30.27% by March 2026.
Separately, Sunil Singhania's Abakkus Diversified Alpha Fund re-entered TTK Healthcare with a 2.07% stake. This move occurred shortly before TTK Healthcare announced on July 23, 2026, the sale of its EVA and Good Home brands to Wipro Enterprises for Rs 256 crore. This cash injection represents nearly 17% of TTK Healthcare's market value. Both investments signal a bet on value unlocking through corporate actions, despite underlying operational challenges in each company.
